NMD Pharma is proud to announce that Monique Schiersing will be joining the BoD of NMD Pharma representing Roche Venture Fond and that Roel Bulthuis has joined the NMD Pharma BoD representing Inkef Capital.
Welcome to Monique Schiersing and Roel Bulthuis as new BoD members
Previous
Previous
NMD Pharma begins first clinical trial
Next
Next